General MedicationsOPHTHALMICGeneric

ILOTYCIN

ERYTHROMYCIN

Standard Dose

0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview ILOTYCIN is listed in Drugs@FDA under application 050368 (NDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength OINTMENT;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DISTA Submission history Latest submission status date: 1993-07-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview ILOTYCIN is listed in Drugs@FDA under application 050368 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength OINTMENT;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DISTA Submission history Latest submission status date: 1993-07-14 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.